115 Mind Blowing mHealth and Telehealth Statistics and Trends

115 Mind Blowing mHealth and Telehealth Statistics and Trends as the third installment of our 4 part Mind Blowing HIT Stats and Facts series.

Thanks to the rise of telehealth and mHealth, a transformation in the delivery of health information and services is quickly taking place, both in the US and abroad. Telehealth use in the US alone is expected to double in the next two years, according to Jonathan Linkous, CEO of the American Telemedicine Association (ATA). So what’s to come from this rather swift shift in the healthcare landscape?

In this third edition of HIT Consultant’s Mind Blowing HIT Stats and Trends series, we take a look at the facts and figures surrounding both telehealth and mHealth to shed light on some potential answers to that rather large question. While the power of both movements has yet to be realized, the influence from their emergence is already evident. Take a look:

mHealth Statistics & Trends

HIMSS Analytics conducted the web-based and telephone-based research with 180 IT professionals in October and November 2012 responded to the 2nd Annual HIMSS Mobile Technology Survey. Survey findings include:

1. Two-thirds of health IT executives indicate that the use of mobile technology will substantially or dramatically impact the delivery of healthcare in the future

2. Use of mobile devices by physicians to view patient information or access non-protected health information is widespread, and the percent of clinicians using apps to actively engage in direct patient care has grown in the past year in several key areas, including:

3. Collection of data at the bedside (45 percent compared to 30 percent);

31. The number of mHealth patents issued by the Patent Office has increased steadily since 2000 (when the number of mHealth patent applications was negligible), and will continue to surge until at least 2014.

32. Large companies are winning the mHealth patent race by obtaining the vast majority of newly-issued mHealth patents.

33. Intellectual Ventures, a non-practicing patent aggregator, is patenting aggressively in the mHealth space. Licensing demands and litigation from IV (and possibly other NPEs) are sure to follow.

34. Almost half of the top twenty mHealth patent holders are not mHealth companies, or even medical device developers.

35. The incidence of mHealth patent infringement conflicts likely will increase as companies become more profitable and patent portfolios mature.

36. The volume of patent litigation in the mHealth industry is low relative to related industries such as the computer, smartphone, and medical device industries.

43. A new meta-analysis of 11 studies shows that mobile device-enabled interventions can help increase people’s physical activity according to study published in the Journal of Medical Internet Research

62. Diagnosis services are expected to comprise nearly 15% of the mobile health market with US $3.4 billion in revenues in 2017

63. A majority of the revenues from Diagnosis services are expected to come from call-centre and mobile telemedicine solutions with approximately US$ 1.7 billion and US$ 1.6 billion in revenue in 2017.

64. Treatment will be the third largest revenue opportunity with around 10% of the total mobile health market share. Wellness and Prevention will comprise approximately 3% and 1% respectively of the total mobile health market.

65. Healthcare Systems Strengthening services and applications are expected to contribute about 6% to the overall mobile health market (corresponding to US$ 1.4 billion) in 2017.

66. Among opportunities in Healthcare Systems Strengthening, Healthcare Practitioner Support will have the largest share with about 5% of the total mobile health market opportunity (US$ 1.1 billion), followed by Administration, Healthcare Surveillance Support, and Emergency Response

67. Mobile operators are expected to be the key beneficiaries of the expected growth in the mobile health market and command about 50% share of the overall market, corresponding to US$ 11.5 billion, in 2017.

68. For mobile operators, a majority of the revenue, nearly US$ 8.8 billion, will accrue from their revenue share from Monitoring services. Diagnosis and Treatment solutions will also be attractive opportunities for operators, and contribute US$ 1 billion and US$ 0.9 billion to operator revenues.

69. 75% of current mobile health deployments in Africa focus on improving the efficiency of healthcare workers and systems

70. Current status of mobile health projects in Africa split by countries where they are implemented

71. Solutions that help spread prevention and awareness messages have also been widely deployed and comprise about 20% of the mobile health developments in the African region

72. Patient treatment and remote monitoring solutions constitute almost 60% of the total mobile health deployments in Europe.

73. The UK leads in mobile health development in Europe, with different kinds of solutions being offered and services being delivered through varied means, from simple SMS to complex apps.

93. The U.S. market for advanced patient monitoring systems has grown from $3.9 billion in 2007 to $8.9 billion in 2011 and is forecast to reach $20.9 billion by 2016 according to a study by Kalorama Information

A previous pilot study conducted by the NHS reviewed three cities with over 6,000 patients suffering from three primary conditions: diabetes, heart failure or COPD. The results include:

95. Remote monitoring reduced mortality rates by 45%

96. 15% reduction in emergency room visits

97. 20% reduction in emergency admissions

98. 14% reduction in bed days

99. 8% reduction in total costs per patient

Source: NHS

100. Patients who receive telemonitoring services and blood pressure management support from a pharmacist are more likely to lower their blood pressure than those who do not receive the extra support, according to a study presented at the American Heart Association’s Quality of Care Outcomes Research Scientific Sessions 2012,

101. After six months, the study found that 71.8% of patients in the group that received telemonitoring support had lowered their blood pressure to healthy levels, compared with 45.2% of patients in the control group.